Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity

References

• Nicklas TA, O’Neil CE. Prevalence of obesity: a public health problem poorly understood. AIMS Public Heal. 2014;1(2):109–122. doi:10.3934/publichealth.2014.2.109
   PubMedGoogle Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA - J Am Med Assoc. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369. doi:10.1136/bmj.m1985
   PubMedGoogle Scholar
• Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York city: prospective cohort study. BMJ. 2020;369. doi:10.1136/bmj.m1966
   PubMed Web of Science ®Google Scholar
• Hernández-Garduño E. Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study. Obes Res Clin Pract. 2020;14(4):375–379. doi:10.1016/j.orcp.2020.06.001
   PubMed Web of Science ®Google Scholar
• Hajifathalian K, Kumar S, Newberry C, et al. Obesity is associated with worse outcomes in COVID-19: analysis of early data from New York city. Obesity. 2020;28(9):1606–1612. doi:10.1002/oby.22923
   PubMed Web of Science ®Google Scholar
• Busetto L, Bettini S, Fabris R, et al. Obesity and COVID-19: an Italian snapshot. Obesity. 2020;28(9):1600–1605. doi:10.1002/oby.22918
   PubMed Web of Science ®Google Scholar
• Hussain A, Mahawar K, Xia Z, Yang W, EL-Hasani S. Obesity and mortality of COVID-19. Meta-analysis. Obes Res Clin Pract. 2020;14(4):295–300. doi:10.1016/j.orcp.2020.07.002
   PubMed Web of Science ®Google Scholar
• Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15(4):277–287. doi:10.1007/s11154-014-9301-0
   PubMed Web of Science ®Google Scholar
• Louwen F, Ritter A, Kreis NN, Yuan J. Insight into the development of obesity: functional alterations of adipose-derived mesenchymal stem cells. Obes Rev. 2018;19(7):888–904. doi:10.1111/obr.12679
   PubMed Web of Science ®Google Scholar
• Febbraio MA. Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol Metab. 2014;25(6):312–319. doi:10.1016/j.tem.2014.02.004
   PubMed Web of Science ®Google Scholar
• Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. Int J Obes. 2013;37(3):333–340. doi:10.1038/ijo.2012.62
   PubMed Web of Science ®Google Scholar
• Ghilotti F, Bellocco R, Ye W, Adami HO, Trolle Lagerros Y. Obesity and risk of infections: results from men and women in the Swedish National March Cohort. Int J Epidemiol. 2019;48(6):1783–1794. doi:10.1093/ije/dyz129
   PubMed Web of Science ®Google Scholar
• Honce R, Schultz-Cherry S. Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol. 2019;10. doi:10.3389/fimmu.2019.01071
   PubMed Web of Science ®Google Scholar
• Hill JH, Solt C, Foster MT. Obesity associated disease risk: the role of inherent differences and location of adipose depots. Horm Mol Biol Clin Investig. 2018;33(2). doi:10.1515/hmbci-2018-0012
   PubMed Web of Science ®Google Scholar
• Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells. 2014;37(5):365–371. doi:10.14348/molcells.2014.0074
   PubMed Web of Science ®Google Scholar
• Cildir G, Akincilar SC, Tergaonkar V. Chronic adipose tissue inflammation: all immune cells on the stage. Trends Mol Med. 2013;19(8):487–500. doi:10.1016/j.molmed.2013.05.001
   PubMed Web of Science ®Google Scholar
• Poblete JMS, Ballinger MN, Bao S, et al. Macrophage HIF-1α mediates obesity-related adipose tissue dysfunction via interleukin-1 receptor-associated kinase M. Am J Physiol - Endocrinol Metab. 2020;318(5):E689–E700. doi:10.1152/ajpendo.00174.2019
   PubMed Web of Science ®Google Scholar
• Wani K, AlHarthi H, Alghamdi A, Sabico S, Al-Daghri NM. Role of NLRP3 inflammasome activation in obesity-mediated metabolic disorders. Int J Environ Res Public Health. 2021;18(2):511. doi:10.3390/ijerph18020511
   PubMed Web of Science ®Google Scholar
• Woo C-Y, Jang JE, Lee SE, Koh EH, Lee K-U. Mitochondrial dysfunction in adipocytes as a primary cause of adipose tissue inflammation. Diabetes Metab J. 2019;43:247. doi:10.4093/dmj.2018.0221
   PubMed Web of Science ®Google Scholar
• Cui H, López M, Rahmouni K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol. 2017;13(6):338–351. doi:10.1038/nrendo.2016.222
   PubMed Web of Science ®Google Scholar
• Vadde R, Gupta MK, Nagaraju GP. Is adipose tissue an immunological organ? Crit Rev Immunol. 2019;39(6):481–490. doi:10.1615/CritRevImmunol.2020033457
   PubMed Web of Science ®Google Scholar
• Russo L, Lumeng CN. Properties and functions of adipose tissue macrophages in obesity. Immunology. 2018;155(4):407–417. doi:10.1111/imm.13002
   PubMed Web of Science ®Google Scholar
• Becker M, Pinhasov A, Ornoy A. Animal models of depression: what can they teach us about the human disease? Diagnostics. 2021;11(1):123. doi:10.3390/diagnostics11010123
   Web of Science ®Google Scholar
• Décarie-Spain L, Sharma S, Hryhorczuk C, et al. Nucleus accumbens inflammation mediates anxiodepressive behavior and compulsive sucrose seeking elicited by saturated dietary fat. Mol Metab. 2018;10:1–13. doi:10.1016/j.molmet.2018.01.018
   PubMed Web of Science ®Google Scholar
• Li B, Leung JCK, Chan LYY, Yiu WH, Tang SCW. A global perspective on the crosstalk between saturated fatty acids and Toll-like receptor 4 in the etiology of inflammation and insulin resistance. Prog Lipid Res. 2020;77. doi:10.1016/j.plipres.2019.101020
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M. NF-B, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309–324. doi:10.1038/nri.2017.142
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lenardo MJ, Baltimore D. 30 years of NF-κB: a blossoming of relevance to human pathobiology. Cell. 2017;168(1–2):37–57. doi:10.1016/j.cell.2016.12.012
   PubMed Web of Science ®Google Scholar
• Aboudounya MM, Heads RJ. COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. 2021. doi:10.1155/2021/8874339.
   Google Scholar
• Nägele MP, Haubner B, Tanner FC, Ruschitzka F, Flammer AJ. Endothelial dysfunction in COVID-19: current findings and therapeutic implications. Atherosclerosis. 2020;314:58–62. doi:10.1016/j.atherosclerosis.2020.10.014
   PubMed Web of Science ®Google Scholar
• De Lorenzo A, Escobar S, Tibiriçá E. Systemic endothelial dysfunction: a common pathway for COVID-19, cardiovascular and metabolic diseases. Nutr Metab Cardiovasc Dis. 2020;30(8):1401–1402. doi:10.1016/j.numecd.2020.05.007
   PubMed Web of Science ®Google Scholar
• Del Turco S, Vianello A, Ragusa R, Caselli C, Basta G. COVID-19 and cardiovascular consequences: is the endothelial dysfunction the hardest challenge? Thromb Res. 2020;196:143–151. doi:10.1016/j.thromres.2020.08.039
   PubMed Web of Science ®Google Scholar
• Hayden MR. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019. J Int Med Res. 2020;48(7):030006052093974. doi:10.1177/0300060520939746
   Web of Science ®Google Scholar
• Coutinho T, Turner ST, Kullo IJ. Adverse effects of long-term weight gain on microvascular endothelial function. Obes Res Clin Pract. 2018;12(5):452–458. doi:10.1016/j.orcp.2018.06.008
   PubMed Web of Science ®Google Scholar
• Korakas E, Ikonomidis I, Kousathana F, et al. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol - Endocrinol Metab. 2020;319(1):E105–E109. doi:10.1152/ajpendo.00198.2020
   PubMed Web of Science ®Google Scholar
• Siddiqi HK, Libby P, Ridker PM. COVID-19 – a vascular disease. Trends Cardiovasc Med. 2021;31(1):1–5. doi:10.1016/j.tcm.2020.10.005
   PubMed Web of Science ®Google Scholar
• Levy JH, Iba T, Connors JM. Editorial commentary: vascular injury in acute infections and COVID-19: everything old is new again. Trends Cardiovasc Med. 2021;31(1):6–7. doi:10.1016/j.tcm.2020.10.011
   PubMed Web of Science ®Google Scholar
• Virdis A, Masi S, Colucci R, et al. Microvascular endothelial dysfunction in patients with obesity. Curr Hypertens Rep. 2019;21(4). doi:10.1007/s11906-019-0930-2
   Web of Science ®Google Scholar
• Houben AJHM, Martens RJH, Stehouwer CDA. Assessing microvascular function in humans from a chronic disease perspective. J Am Soc Nephrol. 2017;28(12):3461–3472. doi:10.1681/ASN.2017020157
   PubMed Web of Science ®Google Scholar
• Jonk AM, Houben AJHM, De Jongh RT, Serné EH, Schaper NC, Stehouwer CDA. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology. 2007;22(4):252–260. doi:10.1152/physiol.00012.2007
   PubMed Web of Science ®Google Scholar
• Boillot A, Zoungas S, Mitchell P, et al. Obesity and the microvasculature: a systematic review and meta-analysis. PLoS One. 2013;8:2. doi:10.1371/journal.pone.0052708
   Google Scholar
• Francischetti EA, Tibirica E, Da Silva EG, Rodrigues E, Celoria BM, De Abreu VG. Skin capillary density and microvascular reactivity in obese subjects with and without metabolic syndrome. Microvasc Res. 2011;81(3):325–330. doi:10.1016/j.mvr.2011.01.002
   PubMed Web of Science ®Google Scholar
• Karaca Ü, Schram MT, Houben AJHM, Muris DMJ, Stehouwer CDA. Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. Diabetes Res Clin Pract. 2014;103(3):382–387. doi:10.1016/j.diabres.2013.12.012
   PubMed Web of Science ®Google Scholar
• Roustit M, Cracowski JL. Assessment of endothelial and neurovascular function in human skin microcirculation. Trends Pharmacol Sci. 2013;34(7):373–384. doi:10.1016/j.tips.2013.05.007
   PubMed Web of Science ®Google Scholar
• Cracowski JL, Roustit M. Current methods to assess human cutaneous blood flow: an updated focus on laser-based-techniques. Microcirculation. 2016;23(5):337–344. doi:10.1111/micc.12257
   PubMed Web of Science ®Google Scholar
• Barata Kasal DA, Britto A, Verri V, De Lorenzo A, Tibirica E. Systemic microvascular endothelial dysfunction is associated with left ventricular ejection fraction reduction in chronic Chagas disease patients. Microcirculation. 2021;28:e12664. doi:10.1111/micc.12664
   PubMed Web of Science ®Google Scholar
• Verri V, Nascimento AR, Brandao AA, Tibirica E. Effects of chronic type 5 phosphodiesterase inhibition on penile microvascular reactivity in hypertensive patients with erectile dysfunction: a randomized crossover placebo-controlled trial. J Hum Hypertens. 2021;35(4):360–370. doi:10.1038/s41371-020-0343-3
   PubMed Web of Science ®Google Scholar
• Matheus ASM, Maria de Fátima B, Clemente EL, et al. Sensibility and specificity of laser speckle contrast imaging according to Endo-PAT index in type 1 diabetes. Microvasc Res. 2018;117:10–15. doi:10.1016/j.mvr.2017.11.002
   PubMed Web of Science ®Google Scholar
• Salgado MAM, Salgado-Filho MF, Reis-Brito JO, Lessa MA, Tibirica E. Effectiveness of laser Doppler perfusion monitoring in the assessment of microvascular function in patients undergoing on-pump coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2014;28(5):1211–1216. doi:10.1053/j.jvca.2014.03.003
   PubMed Web of Science ®Google Scholar
• de Moraes R, Van Bavel D, de Brito Gomes M, Tibiriçá E. Effects of non-supervised low intensity aerobic exercise training on the microvascular endothelial function of patients with type 1 diabetes: a non-pharmacological interventional study. BMC Cardiovasc Disord. 2016;16(1). doi:10.1186/s12872-016-0191-9
   PubMedGoogle Scholar
• Varsamis P, Walther G, Share B, et al. Transient endothelial dysfunction induced by sugar-sweetened beverage consumption may be attenuated by a single bout of aerobic exercise. Microvasc Res. 2018;115:8–11. doi:10.1016/j.mvr.2017.07.003
   PubMed Web of Science ®Google Scholar
• Hellmann M, Roustit M, Gaillard-Bigot F, Cracowski JL. Cutaneous iontophoresis of treprostinil, a prostacyclin analog, increases microvascular blood flux in diabetic malleolus area. Eur J Pharmacol. 2015;758:123–128. doi:10.1016/j.ejphar.2015.03.066
   PubMed Web of Science ®Google Scholar
• Cordovil I, Huguenin G, Rosa G, et al. Evaluation of systemic microvascular endothelial function using laser speckle contrast imaging. Microvasc Res. 2012;83(3):376–379. doi:10.1016/j.mvr.2012.01.004
   PubMed Web of Science ®Google Scholar
• Holowatz LA, Thompson-Torgerson CS, Kenney WL. The human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol. 2008;105(1):370–372. doi:10.1152/japplphysiol.00858.2007
   PubMed Web of Science ®Google Scholar
• Iredahl F, Löfberg A, Sjöberg F, Farnebo S, Tesselaar E. Non-invasive measurement of skin microvascular response during pharmacological and physiological provocations. PLoS One. 2015;10(8):e0133760. doi:10.1371/journal.pone.0133760
   PubMed Web of Science ®Google Scholar
• Tur E, Yosipovitch G, Bar-On Y. Skin reactive hyperemia in diabetic patients: a study by laser Doppler flowmetry. Diabetes Care. 1991;14(11):958–962. doi:10.2337/diacare.14.11.958
   PubMed Web of Science ®Google Scholar
• IJzerman RG, De Jongh RT, Beijk MAM, et al. Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest. 2003;33(7):536–542. doi:10.1046/j.1365-2362.2003.01179.x
   PubMed Web of Science ®Google Scholar
• Yamamoto-Suganuma R, Aso Y. Relationship between post-occlusive forearm skin reactive hyperaemia and vascular disease in patients with Type 2 diabetes - A novel index for detecting micro- and macrovascular dysfunction using laser Doppler flowmetry. Diabet Med. 2009;26(1):83–88. doi:10.1111/j.1464-5491.2008.02609.x
   PubMed Web of Science ®Google Scholar
• Ijzerman RG, Serne EH, Van Weissenbruch MH, De Jongh RT, Stehouwer CDA. Cigarette smoking is associated with an acute impairment of microvascular function in humans. Clin Sci. 2003;104(3):247–252. doi:10.1042/CS20020318
   Web of Science ®Google Scholar
• Halcox JPJ, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106(6):653–658. doi:10.1161/01.CIR.0000025404.78001.D8
   PubMed Web of Science ®Google Scholar
• van der Heijden DJ, van Leeuwen MAH, Janssens GN, et al. Body mass index is associated with microvascular endothelial dysfunction in patients with treated metabolic risk factors and suspected coronary artery disease. J Am Heart Assoc. 2017;6(9). doi:10.1161/JAHA.117.006082
   PubMed Web of Science ®Google Scholar
• Csipo T, Fulop GA, Lipecz A, et al. Short-term weight loss reverses obesity-induced microvascular endothelial dysfunction. GeroScience. 2018;40(3):337–346. doi:10.1007/s11357-018-0028-9
   PubMed Web of Science ®Google Scholar
• Suboc TMB, Dharmashankar K, Wang J, et al. Moderate obesity and endothelial dysfunction in humans: influence of gender and systemic inflammation. Physiol Rep. 2013;1:3. doi:10.1002/phy2.58
   Google Scholar
• La Favor JD, Dubis GS, Yan H, et al. Microvascular endothelial dysfunction in sedentary, obese humans is mediated by NADPH oxidase: influence of exercise training. Arterioscler Thromb Vasc Biol. 2016;36(12):2412–2420. doi:10.1161/ATVBAHA.116.308339
   PubMed Web of Science ®Google Scholar
• Serné EH, De Jongh RT, Eringa EC, IJzerman RG, Stehouwer CDA. Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome. Hypertension. 2007;50:204–211. doi:10.1161/HYPERTENSIONAHA.107.089680
   PubMed Web of Science ®Google Scholar
• Serné EH, Stehouwer CDA, Ter Maaten JC, et al. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation. 1999;99(7):896–902. doi:10.1161/01.CIR.99.7.896
   PubMed Web of Science ®Google Scholar
• De Jongh RT, Serné EH, Ijzerman RG, De Vries G, Stehouwer CDA. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation. 2004;109(21):2529–2535. doi:10.1161/01.CIR.0000129772.26647.6F
   PubMed Web of Science ®Google Scholar
• Serné EH, DeJongh RT, Eringa EC, Ijzerman RG, DeBoer MP, Stehouwer CDA. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome? Essays Biochem. 2006;42:163–176. doi:10.1042/bse0420163
   PubMed Web of Science ®Google Scholar
• Rattigan S, Bussey CT, Ross RM, Richards SM. Obesity, insulin resistance, and capillary recruitment. Microcirculation. 2007;14(4–5):299–309. doi:10.1080/10739680701282796
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Eringa E, Stehouwer CDA. “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005;365(9473):1817–1820. doi:10.1016/S0140-6736(05)66585-3
   PubMed Web of Science ®Google Scholar
• De Jongh RT, Serné EH, Ijzerman RG, De Vries G, Stehouwer CDA. Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes. 2004;53(11):2873–2882. doi:10.2337/diabetes.53.11.2873
   PubMed Web of Science ®Google Scholar
• Ijzerman RG, Voordouw JJ, Van Weissenbruch MM, et al. TNF-α levels are associated with skin capillary recruitment in humans: a potential explanation for the relationship between TNF-α and insulin resistance. Clin Sci. 2006;110(3):361–368. doi:10.1042/CS20050314
   Web of Science ®Google Scholar
• Cheng C, Daskalakis C. Association of adipokines with insulin resistance, microvascular dysfunction, and endothelial dysfunction in healthy young adults. Mediators Inflamm. 2015;2015:1–9. doi:10.1155/2015/594039
   Web of Science ®Google Scholar
• Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HAJ. Microcirculation in hypertension: a new target for treatment? Circulation. 2001;104(6):735–740. doi:10.1161/hc3101.091158
   PubMed Web of Science ®Google Scholar
• Serné EH, Gans ROB, Ter Maaten JC, Tangelder GJ, Donker AJM, Stehouwer CDA. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension. 2001;38(2):238–242. doi:10.1161/01.HYP.38.2.238
   PubMed Web of Science ®Google Scholar
• Serné EH, Gans ROB, Ter Maaten JC, Ter Wee PM, Donker AJM, Stehouwer CDA. Capillary recruitment is impaired in essential hypertension and relates to insulin’s metabolic and vascular actions. Cardiovasc Res. 2001;49(1):161–168. doi:10.1016/S0008-6363(00)00198-X
   PubMed Web of Science ®Google Scholar
• Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ. Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes. 2006;55(5):1436–1442. doi:10.2337/db05-1373
   PubMed Web of Science ®Google Scholar
• Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibirica TE. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens. 2006;19(5):477–483. doi:10.1016/j.amjhyper.2005.10.021
   PubMed Web of Science ®Google Scholar
• De Jongh RT, Ijzerman RG, Serne EH, et al. Visceral and truncal subcutaneous adipose tissue are associated with impaired capillary recruitment in healthy individuals. J Clin Endocrinol Metab. 2006;91(12):5100–5106. doi:10.1210/jc.2006-1103
   PubMed Web of Science ®Google Scholar
• Campbell DJ, Somaratne JB, Prior DL, et al. Obesity is associated with lower coronary microvascular density. PLoS One. 2013;8(11):e81798. doi:10.1371/journal.pone.0081798
   PubMed Web of Science ®Google Scholar
• Cocks M, Shaw CS, Shepherd SO, et al. Sprint interval and moderate-intensity continuous training have equal benefits on aerobic capacity, insulin sensitivity, muscle capillarisation and endothelial eNOS/NAD(P)H oxidase protein ratio in obese men. J Physiol. 2016;594(8):2307–2321. doi:10.1113/jphysiol.2014.285254
   PubMed Web of Science ®Google Scholar
• Martín-Rodríguez JF, Cervera-Barajas A, Madrazo-Atutxa A, et al. Effect of bariatric surgery on microvascular dysfunction associated to metabolic syndrome: a 12-month prospective study. Int J Obes. 2014;38(11):1410–1415. doi:10.1038/ijo.2014.15
   Web of Science ®Google Scholar
• Hwang C-L, Ranieri C, Szczurek MR, et al. The effect of low-carbohydrate diet on macrovascular and microvascular endothelial function is not affected by the provision of caloric restriction in women with obesity: a randomized study. Nutrients. 2020;12(6):1649. doi:10.3390/nu12061649
   PubMed Web of Science ®Google Scholar
• Dimassi S, Chahed K, Boumiza S, et al. Role of eNOS- and NOX-containing microparticles in endothelial dysfunction in patients with obesity. Obesity. 2016;24(6):1305–1312. doi:10.1002/oby.21508
   PubMed Web of Science ®Google Scholar
• Mastrocola R, Penna C, Tullio F, et al. Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways. Oxid Med Cell Longev. 2016;2016:1–11. doi:10.1155/2016/5271251
   Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177–185. doi:10.1038/nature21363
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Ballak DB, Stienstra R, Tack CJ, Dinarello CA, van Diepen JA. IL-1 family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance. Cytokine. 2015;75(2):280–290. doi:10.1016/j.cyto.2015.05.005
   PubMed Web of Science ®Google Scholar
• Ritter A, Kreis NN, Roth S, et al. Restoration of primary cilia in obese adipose-derived mesenchymal stem cells by inhibiting Aurora A or extracellular signal-regulated kinase. Stem Cell Res Ther. 2019;10(1):255. doi:10.1186/s13287-019-1373-z
   PubMed Web of Science ®Google Scholar
• Lee MJ, Kim J, Kim MY, et al. Proteomic analysis of tumor necrosis factor-α-induced secretome of human adipose tissue-derived mesenchymal stem cells. J Proteome Res. 2010;9(4):1754–1762. doi:10.1021/pr900898n
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Millet JK, Whittaker GR. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 2015;202:120–134. doi:10.1016/j.virusres.2014.11.021
   PubMed Web of Science ®Google Scholar
• Mille JK, Whittaker GR. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci U S A. 2014;111(42):15214–15219. doi:10.1073/pnas.1407087111
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020;78(4):779–784.e5. doi:10.1016/j.molcel.2020.04.022
   PubMed Web of Science ®Google Scholar
• Fu J, Zhou B, Zhang L, et al. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol Biol Rep. 2020;47(6):4383–4392. doi:10.1007/s11033-020-05478-4
   PubMed Web of Science ®Google Scholar
• Gupte M, Boustany-Kari CM, Bharadwaj K, et al. ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am J Physiol - Regul Integr Comp Physiol. 2008;295(3):781–788. doi:10.1152/ajpregu.00183.2008
   Web of Science ®Google Scholar
• Li Y, Zhang Z, Yang L, et al. The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience. 2020;23(6):101160. doi:10.1016/j.isci.2020.101400
   PubMed Web of Science ®Google Scholar
• Yanagimachi T, Fujita Y, Takeda Y, et al. Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects. Mol Metab. 2017;6(2):226–231. doi:10.1016/j.molmet.2016.12.009
   PubMed Web of Science ®Google Scholar
• Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors. Allergy. 2020;75(11):2829–2845. doi:10.1111/all.14429
   PubMed Web of Science ®Google Scholar
• Resende PC, Gräf T, Acd P, et al. A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the spike protein was identified within lineage B.1.1.33 circulating in Brazil. Viruses. 2021;13(5):724. doi:10.3390/v13050724
   PubMed Web of Science ®Google Scholar
• Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25–32. doi:10.1016/j.cytogfr.2020.05.003
   PubMed Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. doi:10.1172/JCI137244
   PubMed Web of Science ®Google Scholar
• Sun HJ, Ren XS, Xiong XQ, et al. NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension. Cell Death Dis. 2017;8(10):e3074. doi:10.1038/cddis.2017.470
   PubMedGoogle Scholar
• Yu XH, Zheng XL, Tang CK. Nuclear factor-κB activation as a pathological mechanism of lipid metabolism and atherosclerosis. Adv Clin Chem. 2015;70:1–30. doi:10.1016/bs.acc.2015.03.004
   PubMed Web of Science ®Google Scholar
• Meyerovich K, Ortis F, Cardozo AK. The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes. J Mol Endocrinol. 2018;61(2):F1–F6. doi:10.1530/JME-16-0183
   PubMed Web of Science ®Google Scholar
• Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116(11):3015–3025. doi:10.1172/JCI28898
   PubMed Web of Science ®Google Scholar
• Pfefferle S, Schöpf J, Kögl M, et al. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog. 2011;7(10):e1002331. doi:10.1371/journal.ppat.1002331
   PubMed Web of Science ®Google Scholar
• Meng Y, Pan M, Zheng B, et al. Autophagy attenuates angiotensin II-induced pulmonary fibrosis by inhibiting redox imbalance-mediated NOD-like receptor family pyrin domain containing 3 inflammasome activation. Antioxid Redox Signal. 2019;30(4):520–541. doi:10.1089/ars.2017.7261
   PubMed Web of Science ®Google Scholar
• Lippi G, Mattiuzzi C, Bovo C, Plebani M. Current laboratory diagnostics of coronavirus disease 2019 (COVID-19). Acta Biomed. 2020;91(2):137–145. doi:10.23750/abm.v91i2.9548
   PubMedGoogle Scholar
• Tack CJ, Stienstra R, Joosten LAB, Netea MG. Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol Rev. 2012;249(1):239–252. doi:10.1111/j.1600-065X.2012.01145.x
   PubMed Web of Science ®Google Scholar
• Mastrocola R, Collino M, Penna C, et al. Maladaptive modulations of nlrp3 inflammasome and cardioprotective pathways are involved in diet-induced exacerbation of myocardial ischemia/reperfusion injury in mice. Oxid Med Cell Longev. 2016;2016:1–12. doi:10.1155/2016/3480637
   Web of Science ®Google Scholar
• Ikonomidis I, Pavlidis G, Katsimbri P, et al. Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function. Clin Res Cardiol. 2019;108(10):1093–1101. doi:10.1007/s00392-019-01443-9
   PubMed Web of Science ®Google Scholar
• Costa-Filho RC, Castro-Faria Neto HC, Mengel J et al. Memórias do Instituto Oswaldo Cruz - 0552_Should COVID-19 be branded to Viral Thrombotic Fever? Published 2021. Available from: https://memorias.ioc.fiocruz.br/article/10804/0552-should-covid-19-be-branded-to-viral-thrombotic-fever. Accessed April 30, 2021.
   Google Scholar